Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olumiant (baricitinib)
Pharma
Incyte wins injunction to block Sun's Leqselvi launch
Despite winning an alopecia approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to launch its JAK inhibitor.
Fraiser Kansteiner
Nov 4, 2024 10:01am
Lilly strikes Olumiant licensing deal with Egypt's Eva Pharma
Sep 4, 2024 10:49am
Sun Pharma snags FDA OK for alopecia areata drug Leqselvi
Jul 26, 2024 10:57am
Pfizer's Litfulo boasts an alopecia edge over Lilly's Olumiant
Jun 26, 2023 9:30am
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
EMA cracks down on JAK drugs with new limitations
Oct 28, 2022 10:20am